MB, Levis & Associates’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2K Buy
35
+10
+40% +$3.04K 0.01% 154
2026
Q1
$5.34K Buy
+25
New +$5.59K ﹤0.01% 180

Other funds holding LRCX

MB, Levis & Associates's LRCX Position: Q2 2026 in Review

MB, Levis & Associates increased its Lam Research (LRCX) stake by 40% in Q2 2026, buying an estimated $3.04K and bringing the position to 35 shares worth $15.2K. The position accounts for 0.01% of the portfolio, ranked #154.

MB, Levis & Associates first reported a position in LRCX in Q1 2026 and has held it in 2 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • MB, Levis & Associates held 35 shares of Lam Research worth $15.2K as of Q2 2026.
  • MB, Levis & Associates bought 10 Lam Research shares in Q2 2026, an estimated $3.04K.
  • Lam Research made up 0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #154 holding.
  • MB, Levis & Associates first reported a position in Lam Research in Q1 2026 and has held it in 2 quarters since.
  • 3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.